IBB CNR, Naples, Italy Department of Gastroenterology, University Federico II, Naples, Italy Dept. Biomorphological/Funct. Sci., University Federico II, Naples, Italy Corso Vittorio Emanuele, 670, 80122 Naples, Italy
References Riferimenti: Gertz, M.A., Kyle, R.A., Hepatic amyloidosis (primary (AL) immunoglobulin light chain): The natural history in 80 patients (1988) Am J Med, 85, pp. 73-8
Kyle, R.A., Gertz, M.A., Primary systemic amyloidosis: Clinical and laboratory features in 474 cases (1995) Semin Hematol, 32, pp. 45-49
Brandt, K., Cathacart, E.S., Cohen, A.S., A clinical analysis of the course and prognosis of forty-two patients with amyloidosis (1968) Am J Med, 44, pp. 955-969
Kyle, R.A., Greipp, P.R., Amyloidosis (AL) clinical and laboratory features in 229 cases (1983) Mayo Clin Proc, 58, pp. 665-683
Monzawa, S., Tsukamoto, T., Omata, K., A case with primary amyloidosis of the liver and spleen: Radiologic findings (2002) Eur J Radiol, 41, pp. 237-241
Suzuki, S., Takizawa, K., Nakajima, Y., Sagawa, F., CT findings in hepatic and splenic amyloidosis (1986) J Comput Assist Tomogr, 10, pp. 332-334
Urban, B.A., Fishman, E.K., Goldman, S.M., CT evaluation of amyloidosis: Spectrum of disease (1993) Radiographics, 13, pp. 1295-1308
Kennan, N.M., Evans, C., Case report: Hepatic and splenic calcification due to amyloid (1991) Clin Radiol, 44, pp. 60-61
Scott, W.W., Sanders, R.C., Siegelman, S.S., Irregular fatty infiltration of the liver: Diagnostic dilemmas (1980) AJR, 135, pp. 67-71
Baker, M.K., Wenker, J.C., Cockerill, E.M., Ellis, J.H., Focal fatty infiltration of the liver: Diagnostic imaging (1985) Radiographics, 5, pp. 923-939
Mulher, C.B., Arger, P.H., Coleman, B.G., Stein, M., Non uniform attenuation in computer tomography study of the cirrhotic liver (1979) Radiology, 132, pp. 399-402
Gastineau, D.A., Gertz, M.A., Rosen, C.B., Kyle, R.A., Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis (1991) Am J Hematol, 37, pp. 194-196
Gertz, M. A., Kyle, R. A., Hepatic amyloidosis (primary (AL) immunoglobulin light chain): The natural history in 80 patients (1988) Am J Med, 85, pp. 73-8
Kyle, R. A., Gertz, M. A., Primary systemic amyloidosis: Clinical and laboratory features in 474 cases (1995) Semin Hematol, 32, pp. 45-49
Kyle, R. A., Greipp, P. R., Amyloidosis (AL) clinical and laboratory features in 229 cases (1983) Mayo Clin Proc, 58, pp. 665-683
Urban, B. A., Fishman, E. K., Goldman, S. M., CT evaluation of amyloidosis: Spectrum of disease (1993) Radiographics, 13, pp. 1295-1308
Kennan, N. M., Evans, C., Case report: Hepatic and splenic calcification due to amyloid (1991) Clin Radiol, 44, pp. 60-61
Scott, W. W., Sanders, R. C., Siegelman, S. S., Irregular fatty infiltration of the liver: Diagnostic dilemmas (1980) AJR, 135, pp. 67-71
Baker, M. K., Wenker, J. C., Cockerill, E. M., Ellis, J. H., Focal fatty infiltration of the liver: Diagnostic imaging (1985) Radiographics, 5, pp. 923-939
Mulher, C. B., Arger, P. H., Coleman, B. G., Stein, M., Non uniform attenuation in computer tomography study of the cirrhotic liver (1979) Radiology, 132, pp. 399-402
Gastineau, D. A., Gertz, M. A., Rosen, C. B., Kyle, R. A., Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis (1991) Am J Hematol, 37, pp. 194-196
Hepatic and splenic amyloidosis: Dual-phase spiral CT findings
Although the liver and spleen are frequently involved in primary systemic amyloidosis, the clinical manifestations of hepatic and splenic involvement are usually mild and a dominant symptomatic hepatic presentation is uncommon. We report a case of a 51-year-old woman with giant hepatomegaly, hypertransaminasemia, increase in alkaline phosphatase, and ascites, in whom the findings of dual-phase spiral computed tomography suggested liver and splenic amyloidosis.
Hepatic and splenic amyloidosis: Dual-phase spiral CT findings
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(227 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(287 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(427 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(248 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(432 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote